Copanlisib

CAS: 1032568-63-0

Ref. TM-T6322

Produktinformation

• Name: Copanlisib
• Synonyme: BAY 80-6946, 2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide, 2-Amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide, 5-Pyrimidinecarboxamide, 2-amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-, Aliqopa, Bay 80-6946, Bay 806946
• CAS: 1032568-63-0

Beschreibung

Copanlisib (BAY 80-6946) is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 480.52
• Formel: C₂₃H₂₈N₈O₄
• Reinheit: 99.88%
• Farbe/Form: Solid